TGA
We've updated the Listed Medicine Compliance Reports database with the results of compliance reviews covering 13 listed medicines, including:
- medicines reviewed to check whether they meet stability requirements
- medicines reviewed to check evidence to support health claims about exercise performance
- medicines with non-permitted health claims about:
- nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN),
- fertility, preconception health and use by postpartum and breastfeeding women,
- arthritis, osteoarthritis, irritable bowel syndrome, stomach ulcers, balancing cholesterol levels, autoimmune skin conditions, psoriasis, eczema, and rosacea.
Following the reviews, 8 of these medicines have been cancelled from the Australian Register of Therapeutic Goods (ARTG) and are no longer permitted to be supplied.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
